Kamada Ltd. (KMDA) Social Stream
KAMADA LTD (KMDA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering KAMADA LTD.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 23, 2022
The Trend in the Analyst Price Target
Over the past 21 months, KMDA's average price target has gone up $1.5.
KMDA reports an average of 169.6% for its upside potential over the past 31 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
KMDA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 43 weeks, KMDA's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KMDA as an investment opportunity.
- KAMADA LTD's number of analysts covering the stock is greater than 3.23% of all US stocks.
- KMDA has a lower variance in analysts' estimates than 76.03% of Pharmaceutical Products stocks.
- KAMADA LTD's average analyst price target is higher than 82.83% of Healthcare stocks.
- KAMADA LTD's upside potential (average analyst target price relative to current price) is higher than 164.65% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KAMADA LTD are IMMP, PRQR, and AFMD.
View All Top Stocks by Price Target
Make investment decisions regarding KMDA using the data that counts. Try POWR Ratings for free.